etoposide has been researched along with Chronic Hepatitis C in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhagat, VH; Sepe, T | 1 |
| Amemiya, H; Asakawa, M; Fujii, H; Kono, H; Maki, A; Matsuda, M; Suzuki, T | 1 |
| Chasovskikh, NIu; Litvinova, LS; Novitskiĭ, VV; Radzivil, TT; Riazantseva, NV; Zhukova, OB | 1 |
3 other study(ies) available for etoposide and Chronic Hepatitis C
| Article | Year |
|---|---|
Pancreatic lymphoma complicating early stage chronic hepatitis C.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Etoposide; Fatal Outcome; Female; Hepatitis C, Chronic; Humans; Pancreatic Neoplasms; Prednisone; Rituximab; Vincristine | 2017 |
Role of interleukin-18 and its receptor in hepatocellular carcinoma associated with hepatitis C virus infection.
Topics: Aged; Antineoplastic Agents, Phytogenic; Apoptosis; bcl-X Protein; Carcinoma, Hepatocellular; Cytokines; Electrophoretic Mobility Shift Assay; Etoposide; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interleukin-18; Interleukin-18 Receptor alpha Subunit; Liver Neoplasms; Male; Middle Aged; NF-kappa B; Receptors, Interleukin; Receptors, Interleukin-18; Recombinant Proteins; RNA, Messenger; Survival Rate; X-Linked Inhibitor of Apoptosis Protein | 2006 |
[Modulation of programmed death of the peripheral blood lymphocytes under chronic virus infection].
Topics: Apoptosis; Cells, Cultured; Chronic Disease; Dexamethasone; Encephalitis, Tick-Borne; Etoposide; fas Receptor; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Leukocytes, Mononuclear; Lymphocytes; Membrane Potentials; Mitochondria; Receptors, Tumor Necrosis Factor | 2007 |